Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
What do neglected tropical diseases (NTDs) have to do with women’s health? A recent review entitled, “Effective Health Interventions for Adolescents That Could Be Integrated with Human Papillomavirus Vaccination Programs”, has just been published looking at how combining multiple health interventions with human papillomavirus (HPV) vaccinations increases the effectiveness of HPV delivery.
Last week, the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda released a report – A New Global Partnership: Eradicate Poverty and Transform Economics through Sustainable Development.
During the first week of May, Sustainable Immunization Financing (SIF) Senior Program Officers Devendra Gnawali and Mariya Savchuk were in Phnom Penh, Cambodia where they met with counterparts working on immunization financing issues and organized Sabin’s fifth SIF briefing in that country.
Field research, such as that conducted for clinical trials or disease surveillance, is essential to address the many pervasive health issues in developing countries. It relies on extensive collaboration between research institutions and groups on the ground.